SHARE

Blackstone and TPG in renewed talks over potential $15bn Hologic take-private

The private equity firms are revisiting a possible acquisition of women’s health diagnostics company Hologic, valued at $14.7bn. The business has shown gains in molecular diagnostics and breast care, with fiscal 2026 guidance recently upgraded.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.